The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Biosyent Inc closed at $7.07.

Over the last five days, shares have gained 2.76%, but are down 41.23% for the last year to date. Shares have underperformed the S&P TSX by 15.28% during the last year.

Key company metrics

  • Trailing P/E28.39×
  • P/E 1 year forward26.19×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.25
Updated at previous session's close. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue4334
Total other revenue--------
Total revenue4334
Gross profit3323
Total cost of revenue1111
Total operating expense2222
Selling / general / administrative2111
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income1111
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1111
Income after tax1111
Income tax, total0000
Net income1111
Total adjustments to net income--------
Net income before extra. items1111
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1111
Inc. avail. to common incl. extra. items1111
Diluted net income1111
Dilution adjustment0------
Diluted weighted average shares14141414
Diluted EPS excluding extraordinary itemsvalue per share0.060.070.050.07
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.060.070.050.07